The global cartilage repair market size is expected to reach USD 2,268.8 Million in 2028 and register a revenue CAGR of 14.5% over the forecast period, according to the latest report by Reports and Data. Steady revenue growth of the global cartilage repair market is primarily due to rising incidence of joint injuries owing to obesity, accidents, playing sports, and some other medical conditions/diseases. In most cases, patients with cartilage damage comprise youngsters and adults suffering from knee joint injuries such as meniscal or ligament tears, need knee cartilage repair surgery. Healing of damaged cartilage is a slow process, thus, procedures such as autologous chondrocytes implantation and cell-based cartilage resurfacing are employed to stimulate growth of new cartilage in joints. Cartilage repair and restoration provides significant relief from pain and allow better joint movement, and this helps to delay or prevent onset of arthritis.
Compared with other body tissues, cartilage has a poor blood supply, and therefore has limited potential to heal itself or to support donor cartilage. It is a connective tissue found in various parts of the body, especially joints. Major players are investing in RD of better solutions for cartilage regeneration and repair as degeneration of meniscus (fibrocartilage) tissue affects a large number of patients across the globe. Researchers have recently developed 3D technology that helps to bio-print a 3D hybrid tissue constructed for regenerating cartilage by using specialized bio-inks. These inks comprise hydrogels to develop a new formulation that creates a cell-friendly microenvironment and provides structural integrity.
Top Companies Profiled in the Report Include:
Companies profiled in the global market report includes Zimmer Biomet, Stryker Corporation, DePuy Synthes, Smith Nephew PLC, Vericel Corporation, Osiris Therapeutics Inc., B. Braun Melsungen AG, Anika Therapeutics Inc., Arthrex Inc., and Collagen Solutions PLC.
Cartilage Repair Market Overview:
The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.
Major Highlights of the Cartilage Repairy tests Market Report:
- By Application, the fibrocartilage segment accounted for significantly large revenue share in 2020. Fibrocartilage functions as a joint stabilizer and shock absorber by providing cushion layer in knee joints involved in bearing strain and load. Fibrocartilage in knee joints is much more responsive to joint instability, and hence, in many cases, it acts as an indicator of pending degeneration of cartilage.
- By treatment modality, the cell-based segment accounted for largest revenue share in 2020. Cell-based modality is a kind of biological treatment, which encompasses process of putting new cells along with damaged tissues for treatment of age-related or degenerative diseases. Cartilage is the most appropriate tissue for regeneration purpose. The primary purpose of cell-based treatment for cartilage imperfections is to repair injured joint surfaces using healthy tissues that can endure stresses and strains caused by joint loading.
- North America accounted for largest revenue share in 2020, owing to increasing use of more advanced technologies in the healthcare sector, rising prevalence of obesity, increasing investments in RD of cutting-edge cartilage repair procedures, and increasing healthcare spending. Additionally, presence of various major players is also boosting revenue growth of the market in the region.
- In April 2018, Stryker and AlloSource made an announcement about launch of a cryopreserved osteochondral allograft called ProChondrixCR. It is intended to offer better solutions to patients requiring articular cartilage repair.
- Companies profiled in the global market report include Zimmer Biomet, Stryker Corporation, DePuy Synthes, Smith Nephew PLC, Vericel Corporation, Osiris Therapeutics Inc., B. Braun Melsungen AG, Anika Therapeutics Inc., Arthrex Inc., and Collagen Solutions PLC.
Additionally, the report consists a detailed analysis of the segmentation of the Cartilage Repairy tests Market based on product types and end-use/application offered in the Cartilage Repairy tests Market –
Treatment Modality Outlook (Revenue, USD Billion; 2018–2028)
- Cell-Based
- Chondrocyte Transplantation
- Growth Factor Technology
- Non-Cell-Based
- Tissue Scaffolds
- Cell-Free Composites
- Others
Application Outlook (Revenue, USD Billion; 2018–2028)
- Hyaline
- Fibrocartilage
- Elastic Cartilage
- Others
Treatment Type Outlook (Revenue, USD Billion; 2018–2028)
- Palliative
- Viscosupplementation
- Debridement Lavage
- Intrinsic Repair Stimulus
- Others
End Use Outlook (Revenue, USD Billion; 2018–2028)
- Hospital
- Clinics
- Ambulatory Surgical Centers
- Others
Key Regional Markets Studied in the Report:
- North America (U.S., Canada)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- The Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Request for Customization this report - https://www.reportsanddata.com/request-customization-form/1735
